SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000666
Filing Date
2023-04-14
Accepted
2023-04-14 17:00:51
Documents
82
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K scps-20221231x10k.htm   iXBRL 10-K 1675868
2 EX-10.25 scps-20221231xex10d25.htm EX-10.25 68591
3 EX-10.26 scps-20221231xex10d26.htm EX-10.26 167844
4 EX-23.1 scps-20221231xex23d1.htm EX-23.1 2394
5 EX-31.1 scps-20221231xex31d1.htm EX-31.1 14464
6 EX-31.2 scps-20221231xex31d2.htm EX-31.2 14619
7 EX-32.1 scps-20221231xex32d1.htm EX-32.1 7239
8 EX-32.2 scps-20221231xex32d2.htm EX-32.2 7265
9 GRAPHIC scps-20221231x10k001.jpg GRAPHIC 5127
10 GRAPHIC scps-20221231x10k002.jpg GRAPHIC 16367
11 GRAPHIC scps-20221231x10k003.jpg GRAPHIC 16273
12 GRAPHIC scps-20221231x10k004.jpg GRAPHIC 17053
  Complete submission text file 0001410578-23-000666.txt   7172331

Data Files

Seq Description Document Type Size
13 EX-101.SCH scps-20221231.xsd EX-101.SCH 67755
14 EX-101.CAL scps-20221231_cal.xml EX-101.CAL 46964
15 EX-101.DEF scps-20221231_def.xml EX-101.DEF 220591
16 EX-101.LAB scps-20221231_lab.xml EX-101.LAB 531618
17 EX-101.PRE scps-20221231_pre.xml EX-101.PRE 400404
76 EXTRACTED XBRL INSTANCE DOCUMENT scps-20221231x10k_htm.xml XML 818317
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39788 | Film No.: 23821894
SIC: 2834 Pharmaceutical Preparations